CDX-1307

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCDX-1307
Drug Alias NameCDX-1307MDX-1307
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanVaccines
Mechanisms of ActionMacrophage mannose receptor 1 modulatorsImmunomodulators
TargetsMacrophage mannose receptor 1
Therapy Area/IndicationsUrinary Bladder NeoplasmsOvarian NeoplasmsPancreatic Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelldex TherapeuticsBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsUrinary Bladder NeoplasmsOvarian NeoplasmsPancreatic Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A